Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

corporate social responsibility

- PMLiVE

Pharma reputation lags behind real value, study suggests

Wide 'opportunity gap' for industry

Finding the patient voice

How patients feel and speak about clinical trials

- PMLiVE

UK Sepsis Trust named Communiqué charity of the year

Wins praise from the judges for its HCP engagement

- PMLiVE

Asian patient groups give pharma above average marks for reputation

PatientView survey finds 49% believe sector has a good corporate reputation

- PMLiVE

Pharma’s reputation on the wane, say patient groups

Survey outlines their demands that the industry "must do better" for its patients

- PMLiVE

Call for better patient-focused information in cancer

PatientView survey highlights shortcomings in explaining newer science

- PMLiVE

Driving effective NICE implementation

Clinicians and commissioners are not usually health economists, so can  we expect health economic models to be the only ones that resonate?

- PMLiVE

GSK draws line under Chinese scandal with $20m SEC settlement

Brings corruption investigation to an end with commitment to ongoing remediation reports

- PMLiVE

A new era of collaboration

Looking at the factors driving this change and assessing the benefits

- PMLiVE

The Digital Patient

Earlier this year, the European Commission published a broad-ranging plan to digitise EU industries to help usher in what has become known as the fourth industrial revolution.

- PMLiVE

Pharma’s reputation rises, but pricing still a sore point

Patient group survey sees the industry's corporate reputation increase

- PMLiVE

Patient survey finds pharma falls short on drug pricing

The industry is coming under increasing attack from all sides as price tags rise

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links